Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary bone lymphoma--treatment and outcome.

D R Ford1, D Wilson, S Sothi

  • 1Oncology Centre, Queen Elizabeth Medical Centre, Birmingham B15 2TH, UK. daniel.ford@uclh.nhs.uk

Clinical Oncology (Royal College of Radiologists (Great Britain))
|February 20, 2007
PubMed
Summary

Combined modality treatment for primary bone lymphoma (PBL) offers good local control and survival rates. This study found a 10-year survival of 74% with acceptable toxicity in PBL patients.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Micrometers.

The Bistoury·2023
Same author

Dexamethasone-related adrenal insufficiency in patients with brain and skull base tumours.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2018
Same author

Linear accelerator radiosurgery for arteriovenous malformations: Updated literature review.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2017
Same author

Use of tissue expander in pelvic Ewing's sarcoma treated with radiotherapy.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2013
Same author

Patterns of relapse in glioblastoma multiforme following concomitant chemoradiotherapy with temozolomide.

The British journal of radiology·2013
Same author

A randomised controlled trial to evaluate both the role and the optimal fractionation of radiotherapy in the conservative management of early breast cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2012

Area of Science:

  • Oncology
  • Hematology
  • Orthopedic Oncology

Background:

  • Primary bone lymphoma (PBL) is a rare malignancy.
  • Optimal treatment strategies for PBL require further investigation.

Purpose of the Study:

  • To evaluate the outcomes of combined modality treatment for primary bone lymphoma.
  • To assess survival rates, relapse-free survival, and toxicity in PBL patients.

Main Methods:

  • Retrospective review of 22 patients with histologically confirmed PBL treated between 1985 and 2003.
  • Data collected included demographics, stage, treatment (chemotherapy, radiotherapy, surgery), and outcomes.
  • International Prognostic Index (IPI) was used for risk stratification.

Main Results:

Related Experiment Videos

  • The median age of patients was 50 years; 17 had localized disease, 5 multifocal.
  • All patients received chemotherapy, 19 with anthracycline-based regimens. Radiotherapy was administered to 18 patients.
  • Overall 10-year survival was 74%. Low-risk IPI patients had 92% survival, intermediate-risk 73%. Relapse-free survival was 85%.

Conclusions:

  • Combined modality treatment, including chemotherapy and radiotherapy, achieves good local control and survival in PBL.
  • Treatment demonstrated acceptable toxicity with low rates of local relapse and manageable orthopaedic complications.